Aurobindo Pharma Limited on Sunday informed exchanges about a fire incident at one of its manufacturing facilities operated by its wholly owned stepdown subsidiary, Lyfius Pharma Private Limited, located in the Kakinada SEZ, Andhra Pradesh. The incident took place late evening on April 27, 2025, around 10:00 PM IST.
According to the company’s regulatory filing, the fire broke out in the vicinity of the coal crusher area at its Penicillin-G manufacturing unit. While the fire led to damage of certain ancillary equipment, there was no impact on the core manufacturing infrastructure, and importantly, no injuries were reported among the staff.
Aurobindo Pharma has clarified that the incident is not expected to have any material impact on the operations or financials of the group. The company emphasized that the facility is fully insured, and a thorough assessment of the damage is currently underway.
As a precautionary measure and to facilitate necessary repairs and replacements, operations at the affected plant will be temporarily paused for approximately 20 to 25 days. The company added that it remains committed to resuming full operations at the earliest while adhering to the highest safety and quality standards.
Aurobindo reassured stakeholders that all due protocols are being followed and that operations at other facilities continue as normal.
